Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +5.33% | +0.78% | +5.76% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
Business Summary
Number of employees: 66
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Kevin Church
CTO | Chief Tech/Sci/R&D Officer | 39 | 15-12-31 |
Julie Rathbun
IRC | Investor Relations Contact | - | - |
Robert Renninger
PRN | Corporate Officer/Principal | - | 20-06-30 |
Samantha Willing
HRO | Human Resources Officer | - | Jan. 31 |
Mark Worthington
LAW | General Counsel | 58 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
James Johnson
BRD | Director/Board Member | 67 | 20-07-31 |
Barbara Kosacz
BRD | Director/Board Member | 66 | 21-03-07 |
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Michael Panzara
BRD | Director/Board Member | 57 | 22-03-17 |
Kelly Romano
CHM | Chairman | 62 | 20-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,328,652 | 31,909,063 ( 83.25 %) | 0 | 83.25 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.76% | 93.52M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ATHA Stock
- Company Athira Pharma, Inc.